Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative osmotic agents.

C D Mistry1, R Gokal

  • 1Department of Renal Medicine, Manchester Royal Infirmary, UK.

Blood Purification
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Long-term use of glucose in peritoneal dialysis causes complications. Researchers are exploring alternative osmotic agents to improve patient outcomes and reduce side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Painful Horner's syndrome.

BMJ case reports·2025
Same author

Painful Horner's syndrome.

BMJ case reports·2011
Same author

Painful Horner's syndrome.

Emergency medicine journal : EMJ·2008
Same author

Outcome of pregnancy following renal transplantation.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2004
Same author

Bacillus circulans peritonitis in a patient treated with CAPD.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2004
Same author

End-stage renal disease in Indo-Asians in the North-West of England.

QJM : monthly journal of the Association of Physicians·2003
Same journal

Peritoneal Glucose Uptake Reduction by Sodium-Glucose Co-Transporter 2 Inhibitors in Clinical Peritoneal Dialysis.

Blood purification·2026
Same journal

With the Generalization of AI and Algorithms, Will We Still Need a Nephrologist in the Dialysis Room?

Blood purification·2026
Same journal

Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

Blood purification·2026
Same journal

From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

Blood purification·2026
Same journal

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026
Same journal

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood purification·2026
See all related articles

Area of Science:

  • Nephrology
  • Internal Medicine
  • Biomedical Engineering

Background:

  • Continuous ambulatory peritoneal dialysis (CAPD) is a widely used treatment for end-stage renal disease.
  • A decade of CAPD experience reveals emerging long-term complications.
  • These complications are linked to the use of glucose as an osmotic agent.

Purpose of the Study:

  • To review the long-term complications associated with glucose in CAPD.
  • To explore the need for alternative osmotic agents in peritoneal dialysis.
  • To summarize proposed glucose substitutes for CAPD.

Main Methods:

  • Literature review of studies on CAPD complications.
  • Analysis of the role of glucose as an osmotic agent.
  • Compilation of proposed alternative osmotic agents.

Related Experiment Videos

Main Results:

  • Glucose use in CAPD is associated with direct complications like ultrafiltration issues and metabolic derangements.
  • Indirect complications include hyperosmolality and low pH.
  • Several alternative osmotic agents have been proposed.

Conclusions:

  • Glucose as an osmotic agent in CAPD presents significant long-term challenges.
  • The search for safer and more effective alternatives is crucial for improving CAPD therapy.
  • Further research into alternative osmotic agents is warranted.